OBJECTIVE: To evaluate the effect of specialized young adult diabetes clinic (YAC) on glycemic control in a young adult patients with type 1 diabetes (DM1) transitioning from pediatric to adult diabetes care. RESEARCH DESIGN AND METHODS: HbA1c was retrospectively analyzed through 3 years in 15-25 y/o DM1 patients entering a YAC, and compared to similar patients entering general endocrine clinics (GEC) in a university diabetes center. RESULTS: Ninety-six patients were seen in the YAC, compared to 153 patients in the GEC. No difference in HbA1c was seen at entry (YAC 9.0+/-2.3% versus 8.8+/-2.3%). HbA1c did not change over time in either clinic (mean 3-year HbA1c 8.6+/-2.1% in YAC versus 8.4+/-2.3% in GEC). When the HbA1c values were divided into tertiles, no differences in distribution of baseline HbA1c were seen. Within the highest tertile, the YAC had a greater fall in HbA1c, compared to the GEC. Pump users from both clinics had HbA1c values 1% lower at each time point. CONCLUSIONS: Young adults with DM1 continue to have difficulty achieving target HbA1c values. Earlier use of pump therapy and a specialized YAC for those with the worst glycemic control will benefit this population.
OBJECTIVE: To evaluate the effect of specialized young adult diabetes clinic (YAC) on glycemic control in a young adult patients with type 1 diabetes (DM1) transitioning from pediatric to adult diabetes care. RESEARCH DESIGN AND METHODS: HbA1c was retrospectively analyzed through 3 years in 15-25 y/o DM1patients entering a YAC, and compared to similar patients entering general endocrine clinics (GEC) in a university diabetes center. RESULTS: Ninety-six patients were seen in the YAC, compared to 153 patients in the GEC. No difference in HbA1c was seen at entry (YAC 9.0+/-2.3% versus 8.8+/-2.3%). HbA1c did not change over time in either clinic (mean 3-year HbA1c 8.6+/-2.1% in YAC versus 8.4+/-2.3% in GEC). When the HbA1c values were divided into tertiles, no differences in distribution of baseline HbA1c were seen. Within the highest tertile, the YAC had a greater fall in HbA1c, compared to the GEC. Pump users from both clinics had HbA1c values 1% lower at each time point. CONCLUSIONS: Young adults with DM1 continue to have difficulty achieving target HbA1c values. Earlier use of pump therapy and a specialized YAC for those with the worst glycemic control will benefit this population.
Authors: Alaina M Davis; Rebekah F Brown; Julie Lounds Taylor; Richard A Epstein; Melissa L McPheeters Journal: Pediatrics Date: 2014-10-06 Impact factor: 7.124
Authors: Cheryl L P Vigen; Kristine Carandang; Jeanine Blanchard; Paola A Sequeira; Jamie R Wood; Donna Spruijt-Metz; Robin Whittemore; Anne L Peters; Elizabeth A Pyatak Journal: Diabetes Educ Date: 2018-10-08 Impact factor: 2.140
Authors: Deborah Taira Juarez; Tetine Sentell; Sheri Tokumaru; Roy Goo; James W Davis; Marjorie M Mau Journal: Prev Chronic Dis Date: 2012 Impact factor: 2.830
Authors: Katharine C Garvey; Howard A Wolpert; Erinn T Rhodes; Lori M Laffel; Ken Kleinman; Margaret G Beste; Joseph I Wolfsdorf; Jonathan A Finkelstein Journal: Diabetes Care Date: 2012-06-14 Impact factor: 19.112